SYSTEM STATUS: FDA ACTIVE ISO 13485 Valid MDR Ready
Establishment SinoTitanium
Metals
FEI No. 3033849259
Status Valid
[ISO 13485:2016 VERIFIED] // VDS- PROTOCOL ACTIVE
Sync Status: 2025-Q1 Critical Roadmap Active

2025 Regulatory Forecast.

The medical titanium landscape is shifting. From EU MDR extension deadlines to new ASTM F136-24 revisions, ValidTi provides the forensic data density required to navigate these transitions safely.

High Priority: MDR Transition Global Standards Sync

01 Critical Compliance Vectors

Region: European Union

EU MDR Extension (EU 2023/607)

While the transition deadline for Class IIb implantable devices is extended to 2027/2028, Notified Bodies now require "Evidence of Continuous Compliance" for raw materials.

  • Annex I GSPR Mapping

    Verification of biological and physical material safety.

  • Post-Market Surveillance (PMS)

    Mandatory batch-specific traceability logs for technical files.

Request MDR Data Package →
Region: Global / ASTM

ASTM F136-24 Material Revision

The 2024 revision introduces stricter controls on microstructure uniformity and interstitial element reporting. ValidTi batch processing already exceeds these upcoming benchmarks.

The Interstitial Delta:

"Stricter Oxygen limits (max 0.13%) and mandatory alpha-case removal verification protocols are now standard. ValidTi's forensic MTRs include 100% verification of these delta points."

Compare Technical Standards →

02 2025-2026 Compliance Roadmap

JANUARY 2025

FDA 510(k) Guidance Shift

New performance criteria for dental implants focusing on fatigue life data for Ti-6Al-4V ELI alloys.

MAY 2025

MDR Audit Spike Phase

Expected 40% increase in unannounced audits. ValidTi digital traceability tool is critical for immediate data retrieval.

SEPTEMBER 2025

ISO 5832-3 Sync Phase

International standard synchronization for mechanical properties of annealed titanium products.

Download the 2025 Regulatory SOP Card

A condensed, printable guide (A4 Format) for your compliance team. Includes updated HTS codes, FDA product codes, and MTR audit checklists for the 2025 transition.

Version: 2025.1 // Public Distribution

Navigating Transitions